ISPOR Launches Health Technology Assessment Central

Published May 14, 2018

New Website Offers Comprehensive Repository of Resources and Tools

Lawrenceville, NJ, USA—May 14, 2018—ISPOR, the professional society for health economics and outcomes research (HEOR), announced today the launch of its new Health Technology Assessment Central website. The new website provides a comprehensive repository of resources and tools to support health technology assessment (HTA) and helps to bridge the gap between HEOR and other disciplines that inform HTA and healthcare decisions. HTA is a multidisciplinary process that informs healthcare policy and supports clinical decision making by assessing health technologies in an evidence-based, systematic, transparent, and unbiased way. Health technologies can include biopharmaceuticals, medical devices, diagnostics, etc. HTA has grown in importance as governments and other payers seek to provide the best possible health outcomes at affordable costs. “The new Health Technology Assessment Central is designed to provide a wide-ranging set of resources and tools related to health technology assessment,” noted ISPOR CEO and Executive Director, Nancy S. Berg. “HTA Central was developed in support of ISPOR’s mission to advance HEOR excellence to improve decision making for health globally. Our objective is to offer a dynamic, up-to-date, and comprehensive resource that helps inform healthcare decision makers conducting and utilizing HTA.” The Health Technology Assessment Central is freely available to both ISPOR members and non-members and can be accessed at www.HTAcenter.org.

###

ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg 

Related Stories

Landmark Analysis in Value in Health Uncovers Potential Research Efficiency Gains

Sep 15, 2025

Value in Health, the official journal of ISPOR announced the publication of a landmark scoping review that provides a comprehensive mapping of patient preference studies across key medical domains, revealing the first robust evidence base for advancing meta-analyses and benefit transfer methods in healthcare decision-making.

ISPOR Real-World Evidence Summit 28-30 September 2025 | Tokyo, Japan

Sep 9, 2025

ISPOR announced details for its ISPOR Real-World Evidence Summit 2025: Through The Lens of Asia Pacific. The Summit brings together top experts, decision makers, and industry leaders to explore the latest breakthroughs, share cutting-edge research, and discuss innovative solutions to the region’s most pressing healthcare challenges.

"Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns

Sep 3, 2025

Value in Health, the official journal of ISPOR announced the publication of a new analysis suggesting that the Trump Administration's "Most-Favored Nation" approach to lowering US drug prices by referencing international prices may not achieve its intended goals, based on decades of experience with similar policies in Europe.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×